CMS ISSUES SMALLER REDUCTION IN OPPS PASS-THROUGH PAYMENTSMar 4 2002
(WASHINGTON, DC) - March 4, 2002 - After a four-month delay, the Centers for Medicare and Medicaid Services (CMS) issued a corrected regulation on pass-through payments for innovative medications... |
|
BIO Appears in Fortune Special Section on BiotechnologyMar 4 2002
|
|
BIO Names Genentech’s Susan Desmond-Hellmann to BoardFeb 28 2002
Washington, D.C. (February 28, 2002)-The board of directors of the Biotechnology Industry Organization (BIO) voted unanimously to add Susan Desmond-Hellmann, M.D., M.P.H., to their ranks. Desmond... |
|
BIO Names Amgen’s Dennis Fenton to BoardFeb 28 2002
Washington, D.C. (February 28, 2002)-The Biotechnology Industry Organization (BIO) board of directors has by unanimous vote named Dennis M. Fenton, Ph.D., to their ranks. Fenton is executive vice... |
|
John Davidson, Tom Von Essen Featured Speakers for BIO 2002Feb 27 2002
Washington, D.C. (February 27, 2002)-Two heroes, one from Canada and one from the U.S. were named today as headlining speakers for the BIO 2002 International Convention and Exhibition. John... |
|
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlight of Events for Friday, February 22, 2002Feb 22 2002
WHERE: Waldorf=Astoria Hotel, New York 10:40 a.m. – 12: 00 p.m.Investor Session 13Jade Room Enhancing the Therapeutic Profile of Anti-cancer... |
|
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Thursday, February 21, 2002Feb 21 2002
Where: Waldorf=Astoria Hotel, New York9:30 - 10:30 a.m.Press ConferenceHerbert Hoover Room Accenture Press Conference - Accenture... |
|
Two Companies Awarded 2002 Helix Award for Corporate ExcellenceFeb 21 2002
New York– (February 21, 2002) – CV Therapeutics and Isis Pharmaceuticals were presented with the seventh Annual Helix Award at the Biotechnology Industry Organization’s CEO &... |
|
BIO Statement on NAS Report on Transgenic PlantsFeb 21 2002
(Dr. Michael J. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in response to today’s National... |
|
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Wednesday, February 20, 2002Feb 20 2002
8:00 - 9:20 a.m.Opening PlenaryGrand Ballroom2001: A Record Year in Biotech M & A - This panel will feature executives from Vertex Pharmaceuticals,... |
